Early Phase 1 Epilepsy Trial, Recruiting NCT07116421 Sponsor: Vanderbilt University Medical Center Condition: Epilepsy
Back to Epilepsy

Early Phase 1 Epilepsy Trial, Recruiting

NCT07116421
Recruiting Early Phase 1

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People aged 18 or older who have epilepsy
  • People admitted as inpatients to the Epilepsy Monitoring Unit (EMU) at Vanderbilt University Medical Center
  • People having their brain activity monitored through EEG (a test that records electrical signals in the brain) for at least 48 hours, without any changes to seizure medications or other treatments during that time

Who may not be able to join:

  • People under the age of 18
  • People whose EEG monitoring without any treatment changes lasts less than 48 hours
  • People who are not receiving EEG monitoring as part of their hospital stay

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 28 July 2026
Early Phase 1 studies are small, early exploratory studies that come before the main Phase 1 to 3 testing, so a standard phase success rate does not apply.

Contact this trial

Phone: 925-378-9234

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Early Phase 1
Registry
ClinicalTrials.gov
Start date
1 July 2025
Est. completion
8 May 2027

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Number of ictal episodes; Number of apneic episodes

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov